Calorie restriction may be key to asthma prevention, finds study

Published On 2019-02-01 13:40 GMT   |   Update On 2019-02-01 13:40 GMT
Calorie restriction may be key to asthma prevention, finds a new study. The report of study has appeared in Scientific Reports.

Johns Hopkins Medicine researchers have reported that a low-calorie diet prevented asthma symptoms regardless of the diet's fat and sugar content in animal experiments. They also found that obesity resulting from a high-calorie diet led to asthma symptoms in the animals by causing lung inflammation, and a drug that blocks inflammation eased those symptoms.


Asthma is a common chronic lung disease in which inflammation causes narrowing of airways, leading to wheezing, coughing, shortness of breath and chest tightness. According to the U.S. Centers for Disease Control and Prevention, 38.8 per cent of adults with asthma are obese, much higher than the obesity rate in adults without asthma, which stands at 26.8 per cent. But, the biological mechanisms underlying obesity-related asthma symptoms and risk have remained somewhat unclear.


"Previous studies suggested that the high fat or high sugar content in diets that led to obesity promoted inflammation and caused asthma," says Vsevolod Polotsky, M.D., Ph.D., professor of pulmonary and critical care medicine at the Johns Hopkins University School of Medicine, and senior author of the study. "However, our study shows that obesity leads to inflammation-associated asthma symptoms regardless of the makeup of the diet and that restricting calories by any means may prevent or treat asthma by reducing inflammation."


In this study, researchers fed normal male mice one of four diets: (1) a low-calorie chow diet, which is a standard laboratory diet of crunchy food pellets without calorie restrictions; (2) a calorie-dense diet containing more calories and fat per gram; (3) a calorie-dense diet containing more fat per gram and supplemented with additional sugar; and (4) a calorie-dense, high transfat diet supplemented with sugar. Furthermore, separate groups of mice were fed the calorie-dense diets, but their daily food intake was restricted to match the number of calories that mice eat on a low-calorie diet.


After eight weeks, mice on any high-calorie diet, whose eating wasn't restricted, gained at least 7 grams more than mice on the low-calorie diet or mice on food-restricted, calorie-dense diets.


The researchers went on to evaluate the animals' lung function to see if the mice developed asthma symptoms by measuring the narrowing of lung airways when the mice inhaled different doses of methacholine, a drug that causes airways to constrict. When given a 30 milligrams per millilitre dose of methacholine, mice on all kinds of high-calorie diets whose eating wasn't restricted had their airways constricted at least 6.3 times more than baseline, while mice on low-calorie diets or food-restricted mice on high-calorie diets had their airways constricted at most 4.7 times more than baseline. The results of these tests--similar to those used to screen for or diagnose asthma in people--indicated that mice on high-calorie diets developed asthma symptoms, as well as obesity.


In the new experiments, researchers sought to further pin down the links between obesity, inflammatory response and asthma by first feeding mice high-fat diets for eight weeks. Then they injected one group of mice with a drug called anakinra every day during the last two weeks to block the activity of IL-β protein--and thus inflammation--by preventing it from reaching its targeting sites. Because of its anti-inflammatory properties, anakinra is used to treat rheumatoid arthritis.


At the end of eight weeks, when given a 30 milligram per millilitre dose of methacholine to test their airway responsiveness, obese mice on the drug anakinra had their airways constricted 2.9 times more than baseline, lower than the 5.1 times increase observed in millilitre not given the drug.


For more details click on the link: DOI: 10.1038/s41598-018-36651-2

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News